Clinical Trials Browser

Phase 1 × Multiple Myeloma × Indium × Clear all

NCT05363111 2025-10-29

Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma

Phase 1 Recruiting

Multiple Myeloma